Polygenic control of antibody production and correlation with vaccine induced resistance to rabies virus in high and low antibody responder mice. 1996

M De Franco, and S Massa, and R C Vassão, and M Siqueira, and O A Sant'Anna
Laboratório de Imunogenética, Instituto Butantan, São Paulo, Brazil.

The amplification of "high" (H) and "low" (L) multispecific antibody responses achieved respectively by H and L lines of selection GP represents a valuable tool in the genetic study of host-infection interactions. These lines were obtained by bidirectional selective breeding for high (HGP) or low (LGP) antibody production to natural complex antigens. HGP and LGP parental lines and reciprocal F1 hybrids, as well as their F2 segregants and backcrosses were submitted to immunization and challenge with rabies virus CVS strain. Acquired resistance was 1000-fold higher in HGP than LGP mice, with a dominance effect to low antibody production observed in F1 hybrids. An association between high antibody response and acquired resistance (P < 0.001) in F2 segregant mice was noticed. The genetic study was performed in these several populations, with a single dose of 104.5-fold LD50 CVS. We could demonstrate 3 independent loci regulating the anti-rabies antibody production, that are distinct, at least in part, from the 10 genes controlling the antigen selection response (sheep erythrocytes) of selection GP.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D008297 Male Males
D011818 Rabies Acute VIRAL CNS INFECTION affecting mammals, including humans. It is caused by RABIES VIRUS and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals. Important animal vectors include the dog, cat, bat, fox, raccoon, skunk, and wolf. Encephalitic Rabies,Furious Rabies,Hydrophobia,Paralytic Rabies,Lyssa,Furious Raby,Lyssas,Rabies, Encephalitic,Rabies, Furious,Raby, Furious
D011819 Rabies Vaccines Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis. Rabies Human Diploid Cell Vaccine,Rabies Vaccine,Vaccine, Rabies,Vaccines, Rabies
D011820 Rabies virus The type species of LYSSAVIRUS causing rabies in humans and other animals. Transmission is mostly by animal bites through saliva. The virus is neurotropic multiplying in neurons and myotubes of vertebrates. Rabies viruses
D002678 Chimera An individual that contains cell populations derived from different zygotes. Hybrids,Chimeras,Hybrid
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

M De Franco, and S Massa, and R C Vassão, and M Siqueira, and O A Sant'Anna
November 1982, Clinical and experimental immunology,
M De Franco, and S Massa, and R C Vassão, and M Siqueira, and O A Sant'Anna
January 1990, Research in virology,
M De Franco, and S Massa, and R C Vassão, and M Siqueira, and O A Sant'Anna
July 1979, Infection and immunity,
M De Franco, and S Massa, and R C Vassão, and M Siqueira, and O A Sant'Anna
February 1991, Journal of interferon research,
M De Franco, and S Massa, and R C Vassão, and M Siqueira, and O A Sant'Anna
August 1998, Scandinavian journal of immunology,
M De Franco, and S Massa, and R C Vassão, and M Siqueira, and O A Sant'Anna
February 1983, The Journal of experimental medicine,
M De Franco, and S Massa, and R C Vassão, and M Siqueira, and O A Sant'Anna
August 1982, Parasitology,
M De Franco, and S Massa, and R C Vassão, and M Siqueira, and O A Sant'Anna
April 1977, European journal of immunology,
M De Franco, and S Massa, and R C Vassão, and M Siqueira, and O A Sant'Anna
January 2011, Advances in preventive medicine,
M De Franco, and S Massa, and R C Vassão, and M Siqueira, and O A Sant'Anna
August 2000, Medical mycology,
Copied contents to your clipboard!